Rare diseases
303 results
201 - 300
Red eye - Recurrent infections and immunodeficiencies in children
Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults- Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
- Psychosocial interventions for preventing and treating depression in dialysis patients
- Polyneuropathies
- Benign gynaecological lesions and tumours
- Dermatological diagnosis at a glance
- Enzyme replacement therapy for late‐onset Pompe disease
- Systemic lupus erythematosus (SLE)
- Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita
- Immunosuppressive treatment for non‐systemic vasculitic neuropathy
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Assessment and treatment of a patient with bleeding diathesis
- Notification and support for people exposed to the risk of Creutzfeldt‐Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)
- Chronic diseases and pregnancy
- Examining a patient with a thyroid complaint
- Drug treatment for myotonia
- Bile acids for primary sclerosing cholangitis: Cochrane systematic review
- Treatment for periodic paralysis: Cochrane systematic review
- Blood transfusion: indications, administration and adverse reactions
- Palliative care interventions for people with multiple sclerosis
- Interventions for preventing falls in people with multiple sclerosis
- Non pharmacological interventions for spasticity in multiple sclerosis: Cochrane systematic review
- Central venous catheter (CVC) removal for patients of all ages with candidaemia
- Iridotomy to slow progression of visual field loss in angle‐closure glaucoma
- Occupational guidance in school health care
- Daclizumab for relapsing remitting multiple sclerosis
- Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia: Cochrane systematic review
- Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Abdominal drainage versus no drainage post‐gastrectomy for gastric cancer
- Neuropsychological rehabilitation for multiple sclerosis: Cochrane systematic review
- Sodium channel blockers for neuroprotection in multiple sclerosis
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Telerehabilitation for persons with multiple sclerosis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Mitoxantrone for multiple sclerosis: Cochrane systematic review
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis
- Vaccinations
- Hereditary susceptibility to cancer
- Down's syndrome
- Vaccines for preventing infections in adults with haematological malignancies
- Information provision for people with multiple sclerosis
- Route of antibiotic prophylaxis for prevention of cerebrospinal fluid‐shunt infection
- Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes: Cochrane systematic review
- Intermittent preventive treatment for malaria in children living in areas with seasonal transmission
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Digital tracking, provider decision support systems, and targeted client communication via mobile devices to improve primary health care
- Hormonal contraception
- Treatment of epilepsy in adults
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis
- Exercise therapy for fatigue in multiple sclerosis
- Interventions for managing medication‐related osteonecrosis of the jaw
- Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain
- Interventions for bullous pemphigoid
- Antibiotics for acute otitis media in children
- Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis
- Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
- Diagnosis and treatment of childhood asthma
- Chronic heart failure
- Head injuries in children
- Gout and pseudogout
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis: Cochrane systematic review
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine
- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Recognition of alcohol and drug abuse
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
- Respiratory muscle training for multiple sclerosis
- Vitamin D for the management of multiple sclerosis
- Fingolimod for relapsing‐remitting multiple sclerosis
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Intravenous immunoglobulin for the treatment of childhood encephalitis
- Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies
- Inguinal and genital skin problems
- Mental disorders due to somatic disease
- N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
- Pharmacological treatment of depression
- Deep vein thrombosis
- Siponimod for multiple sclerosis
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Antenatal clinics: care and examinations
- Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
- (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Topical tacrolimus for atopic dermatitis
- Polycystic kidney disease
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
- Interventions targeted at women to encourage the uptake of cervical screening
- Vaccines for preventing rotavirus diarrhoea: vaccines in use
- Ivermectin and permethrin for treating scabies
- Teriflunomide for multiple sclerosis
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Postinfectious syndromes
- Management of acute atrial fibrillation
- Abnormal menstrual bleeding